Janusz Jankowski
Overview
Explore the profile of Janusz Jankowski including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
77
Citations
5677
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Dighe S, Chen J, Yan L, He Q, Gharahkhani P, Onstad L, et al.
Carcinogenesis
. 2020 Dec;
42(3):369-377.
PMID: 33300568
Genome-wide association studies (GWAS) of esophageal adenocarcinoma (EAC) and its precursor, Barrett's esophagus (BE), have uncovered significant genetic components of risk, but most heritability remains unexplained. Targeted assessment of genetic...
12.
Bennett C, Green S, deCaestecker J, Almond M, Barr H, Bhandari P, et al.
Cochrane Database Syst Rev
. 2020 May;
5:CD007334.
PMID: 32442322
Background: Barrett's oesophagus is one of the most common pre-malignant lesions in the world. Currently the mainstay of therapy is surgical management of advanced cancer but this has improved the...
13.
Franklin J, Jankowski J
F1000Res
. 2020 May;
9.
PMID: 32399195
Oesophageal cancer is a common cancer that continues to have a poor survival. This is largely in part due to its late diagnosis and early metastatic spread. Currently, screening is...
14.
An J, Gharahkhani P, Law M, Ong J, Han X, Olsen C, et al.
Nat Commun
. 2019 Dec;
10(1):5617.
PMID: 31796739
An amendment to this paper has been published and can be accessed via a link at the top of the paper.
15.
Bohmer A, Hecker J, Schroder J, Gharahkhani P, May A, Gerges C, et al.
Cancer Epidemiol Biomarkers Prev
. 2019 Nov;
29(2):427-433.
PMID: 31748258
Background: Obesity is a major risk factor for esophageal adenocarcinoma (EA) and its precursor Barrett's esophagus (BE). Research suggests that individuals with high genetic risk to obesity have a higher...
16.
Longcroft-Wheaton G, Fogg C, Chedgy F, Kandiah K, Murray L, Dewey A, et al.
Endoscopy
. 2019 Oct;
52(1):29-36.
PMID: 31618768
Background: The aims of this study were to compare neoplasia detection rates for nontargeted biopsies (Seattle protocol) versus acetic acid-targeted biopsies (Portsmouth protocol) during Barrett's surveillance and to explore feasibility,...
17.
An J, Gharahkhani P, Law M, Ong J, Han X, Olsen C, et al.
Nat Commun
. 2019 Sep;
10(1):4219.
PMID: 31527586
Gastroesophageal reflux disease (GERD) is caused by gastric acid entering the esophagus. GERD has high prevalence and is the major risk factor for Barrett's esophagus (BE) and esophageal adenocarcinoma (EA)....
18.
Joharatnam-Hogan N, Cafferty F, Hubner R, Swinson D, Sothi S, Gupta K, et al.
Lancet Gastroenterol Hepatol
. 2019 Sep;
4(11):854-862.
PMID: 31477558
Background: Preclinical, epidemiological, and randomised data indicate that aspirin might prevent tumour development and metastasis, leading to reduced cancer mortality, particularly for gastro-oesophageal and colorectal cancer. Randomised trials evaluating aspirin...
19.
Dong J, Gharahkhani P, Chow W, Gammon M, Liu G, Caldas C, et al.
Clin Gastroenterol Hepatol
. 2019 Feb;
17(11):2227-2235.e1.
PMID: 30716477
Background & Aims: Epidemiology studies of circulating concentrations of 25 hydroxy vitamin D (25(OH)D) and risk of esophageal adenocarcinoma (EAC) have produced conflicting results. We conducted a Mendelian randomization study...
20.
Vrana D, Matzenauer M, Neoral C, Aujesky R, Vrba R, Melichar B, et al.
Int J Mol Sci
. 2018 Dec;
20(1).
PMID: 30577521
Esophageal and gastric cancers represent tumors with poor prognosis. Unfortunately, radiotherapy, chemotherapy, and targeted therapy have made only limited progress in recent years in improving the generally disappointing outcome. Immunotherapy...